WASHINGTON. D.C. (REUTERS) The strange bad luck of the pharmaceutical company Dawn Biozyme continued today, as legislators effectively put a halt to all business operations. This investigation by the FDA comes as further shock to a company which earlier this year sustained the explosion of its headquarters, the grisly robbery/murder of one of its key scientific team, Albert Finely and his wife, and the suicide of its chairman and CEO, James Corazini. The firm, once valued at $400 million, has had all assets frozen and all employees subpoenaed. Sources inside the investigation suggest the firm was engaged in illegal research into genetic crop engineering.